Pubblicazioni

Is There a Gender Difference in the Response to onabotulinumtoxinA in Chronic Migraine? Insights from a Real-Life European Multicenter Study on 2879 Patients

2021 - PAIN AND THERAPY

Ornello, R.; Ahmed, F.; Negro, A.; Miscio, A. M.; Santoro, A.; Alpuente, A.; Russo, A.; Silvestro, M.; Cevoli, S.; Brunelli, N.; Vernieri, F.; Grazzi, L.; Baraldi, C.; Guerzoni, S.; Andreou, A. P.; Lambru, G.; Kamm, K.; Ruscheweyh, R.; Russo, M.; Torelli, P.; Filatova, E.; Latysheva, N.; Gryglas-Dworak, A.; Straburzynski, M.; Butera, C.; Colombo, B.; Filippi, M.; Pozo-Rosich, P.; Martelletti, P.; Sacco, S.

Early Management of OnabotulinumtoxinA Treatment in Chronic Migraine. Insights from a Real-Life European Multicenter Study

2021 - PAIN AND THERAPY

Ornello, R.; Ahmed, F.; Negro, A.; Miscio, A. M.; Santoro, A.; Alpuente, A.; Russo, A.; Silvestro, M.; Cevoli, S.; Brunelli, N.; Vernieri, F.; Grazzi, L.; Baraldi, C.; Guerzoni, S.; Andreou, A. P.; Lambru, G.; Frattale, I.; Kamm, K.; Ruscheweyh, R.; Russo, M.; Torelli, P.; Filatova, E.; Latysheva, N.; Gryglas-Dworak, A.; Straburzynski, M.; Butera, C.; Colombo, B.; Filippi, M.; Pozo-Rosich, P.; Martelletti, P.; Sacco, S.

What is changing in chronic migraine treatment? An algorithm for onabotulinumtoxinA treatment by the Italian chronic migraine group

2020 - EXPERT REVIEW OF NEUROTHERAPEUTICS

Sacco, S.; Russo, A.; Geppetti, P.; Grazzi, L.; Negro, A.; Tassorelli, C.; Tedeschi, G.; Martelletti, P.

Current and emerging evidence-based treatment options in chronic migraine. a narrative review

2019 - THE JOURNAL OF HEADACHE AND PAIN

Agostoni, E. C.; Barbanti, P.; Calabresi, P.; Colombo, B.; Cortelli, P.; Frediani, F.; Geppetti, P.; Grazzi, L.; Leone, M.; Martelletti, P.; Pini, L. A.; Prudenzano, M. P.; Sarchielli, P.; Tedeschi, G.; Russo, A.

Optimizing the long-term management of chronic migraine with onabotulinumtoxinA in real life

2018 - EXPERT REVIEW OF NEUROTHERAPEUTICS

Tassorelli, Cristina; Tedeschi, Gioacchino; Sarchielli, P; Pini, Luigi Alberto; Grazzi, Licia; Geppetti, Pierangelo; De Tommaso, Marina; Aguggia, Marco; Cortelli, P; Martelletti, Paolo

The journey from genetic predisposition to medication overuse headache to its acquisition as sequela of chronic migraine

2018 - THE JOURNAL OF HEADACHE AND PAIN

Martelletti, Paolo

Guideline on the use of onabotulinumtoxinA in chronic migraine. a consensus statement from the European Headache Federation

2018 - THE JOURNAL OF HEADACHE AND PAIN

Bendtsen, Lars; Sacco, Simona; Ashina, Messoud; Mitsikostas, Dimos; Ahmed, Fayyaz; Pozo-Rosich, Patricia; Martelletti, Paolo

Adolescence transitional care in neurogenic detrusor overactivity and the use of OnabotulinumtoxinA: a clinical algorithm from an Italian consensus statement

2017 - NEUROUROLOGY AND URODYNAMICS

Palleschi, G; Mosiello, G; Iacovelli, V; Musco, S; Del Popolo, G; Giannantoni, A; Carbone, A; Carone, R; Tubaro, A; De Gennaro, M; Marte, A; Finazzi AgrÃ², E.

A two years open-label prospective study of OnabotulinumtoxinA 195 U in medication overuse headache. a real-world experience

2015 - THE JOURNAL OF HEADACHE AND PAIN

Negro, Andrea; Curto, Martina; Lionetto, L; Martelletti, Paolo

OnabotulinumtoxinA intradetrusorial injections improve sexual function in female patients affected by multiple sclerosis: preliminary results

2015 - WORLD JOURNAL OF UROLOGY

Giannantoni, Antonella; Proietti, Silvia; Giusti, Guido; Gubbiotti, Marilena; Millefiorini, Enrico; Costantini, Elisabetta; Berardelli, Alfredo; Conte, Antonella

Ricerc@Sapienza